MedPath

FEMINEX 300 TAB

FEMINEX 300 TAB

Discontinued
DIN Number

00660124

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

santé naturelle (ag) ltée

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00660124
AIG Number1017357002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A11JB VITAMINS WITH MINERALS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification88:28.01*
Health Canada Classification

ACTIVE INGREDIENTS (10)

ASCORBIC ACIDActive
Strength: 50 MG / TAB
Monograph: ASCORBIC ACID
CALCIUM (CALCIUM CARBONATE)Active
Strength: 300 MG / TAB
Monograph: CALCIUM (CALCIUM CARBONATE)
FOLIC ACIDActive
Strength: .03 MG / TAB
Monograph: FOLIC ACID
IRON (FERROUS FUMARATE)Active
Strength: 5 MG / TAB
Monograph: IRON (FERROUS FUMARATE)
MAGNESIUM (MAGNESIUM OXIDE)Active
Strength: 25 MG / TAB
Monograph: MAGNESIUM (MAGNESIUM OXIDE)
VITAMIN A (RETINOL PALMITATE)Active
Strength: 1500 UNIT / TAB
Monograph: VITAMIN A (RETINOL PALMITATE)
VITAMIN B12Active
Strength: 4.5 MCG / TAB
Monograph: VITAMIN B12
VITAMIN B6Active
Strength: 1 MG / TAB
Monograph: VITAMIN B6
VITAMIN DActive
Strength: 130 UNIT / TAB
Monograph: VITAMIN D
VITAMIN EActive
Strength: 8 UNIT / TAB
Monograph: VITAMIN E

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.